Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

MenoGeniX receives grant from NIA for drug to treat menopausal hot flashes

May 7, 2018

OTL-200 receives rare pediatric disease designation from the FDA

May 4, 2018

TES Pharma discovers ACMSD inhibitors

May 3, 2018

FDA grants fast track designation to RGX-121 gene therapy

May 3, 2018

Hanmi opens first-in-human trial of HM-15211 in healthy obese subjects

May 3, 2018

YW-1128, a WNT pathway inhibitor, shows promising in vivo results for metabolic disorders

May 3, 2018

Crysvita launched in U.S. for X-linked hypophosphatemia

May 3, 2018

FDA grants orphan drug designation to ELX-02 for cystinosis

April 30, 2018

EMA committee recommends approval of Prolia for bone loss associated with glucocorticoid therapy

April 30, 2018

INSYS initiates phase II study of cannabidiol oral solution for treatment of Prader-Willi syndrome

April 30, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...